Drug Neuroscience

Emgality

Payments companies reported to CMS as associated with Emgality. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.5Massociated payments (2023-2025)
26,420clinicians with associated payments
3companies reporting

By year

2023 $1.1M
2024 $362K
2025 $71K

Payments reported as associated with Emgality, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurology (Psychiatry & Neurology) $513K
Family Medicine $217K
Family $204K
Internal Medicine $137K
Physician Assistant $110K
Nurse Practitioner $62K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Emgality

These are the largest totals companies reported as associated with Emgality. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Stewart Tepper Stamford, CT Neurology (Psychiatry & Neurology) $59,294.10
Andrew Blumenfeld Carlsbad, CA Neurology (Psychiatry & Neurology) $26,287.47
Nada Hindiyeh San Francisco, CA Neurology (Psychiatry & Neurology) $18,565.26
Jan Brandes Nashville, TN $18,450.00
Peter Mcallister Fairfield, CT Neurology (Psychiatry & Neurology) $18,338.78
Stephanie Nahas-Geiger Philadelphia, PA Neurology (Psychiatry & Neurology) $17,728.06
Wade Cooper Ann Arbor, MI Neurology (Psychiatry & Neurology) $15,649.35
Hope O'Brien Cincinnati, OH Neurology With Special Qualifications In Child Neurology $15,486.90
Andrew Charles Los Angeles, CA Neurology (Psychiatry & Neurology) $9,425.00
Paul Mathew Cambridge, MA Neurology (Psychiatry & Neurology) $7,675.24

Prescribed Emgality?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.